Indian Pharmaceutical Companies and Accessibility of Drugs under TRIPS

Sudip Chaudhuri

Chapter 10 in Commercialization of Health Care, 2005, pp 155-169 from Palgrave Macmillan

Abstract: Abstract Before the creation of the World Trade Organization (WTO) as the new permanent international trade organization, individual countries had the freedom to have their own patent laws. India was one of the countries which introduced a new patent law: the British Patents and Designs Act, 1911 was replaced by the Patents Act, 1970. The most striking feature of the new law was that it abolished product patents in drugs (and food). India had a long tradition of drug manufacturing. But the full potential could not be realized because of the constraints imposed by the Patents Act of 1911. The multinational corporations (MNCs) holding the drug patents used the then existing patent law to prevent the Indian generic companies from producing the new drugs.

Keywords: World Trade Organization; Indian Company; Compulsory Licence; Bulk Drug; Product Patent (search for similar items in EconPapers)
Date: 2005
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:sopchp:978-0-230-52361-6_10

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230523616

DOI: 10.1057/9780230523616_10

Access Statistics for this chapter

More chapters in Social Policy in a Development Context from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().